TB determined: tuberculous osteomyelitis

Am J Med. 2014 Mar;127(3):198-201. doi: 10.1016/j.amjmed.2013.12.001. Epub 2013 Dec 12.

Authors

Dan Lebowitz¹, Line Wolter², Christiane Zenklusen³, Amine Chouiter⁴, Raffaele Malinverni²

Affiliations

¹ Department of Internal Medicine, Pourtalès Hospital, Neuchâtel, Switzerland. Electronic address: Dan.Lebowitz@hcuge.ch.
² Department of Internal Medicine, Pourtalès Hospital, Neuchâtel, Switzerland.
³ Department of Rheumatology, Pourtalès Hospital, Neuchâtel, Switzerland.
⁴ Department of Radiology, Pourtalès Hospital, Neuchâtel, Switzerland.

PMID: 24333617
DOI: 10.1016/j.amjmed.2013.12.001

No abstract available

Publication types

Case Reports

MeSH terms

Antitubercular Agents / therapeutic use*
Aza Compounds / administration & dosage
Bone Neoplasms / diagnosis
Diagnosis, Differential
Drug Therapy, Combination
Ethambutol / administration & dosage
Fluorodeoxyglucose F18
Fluoroquinolones
Humans
Lung / pathology
Magnetic Resonance Imaging
Male
Middle Aged
Moxifloxacin
Osteomyelitis / diagnosis*
Osteomyelitis / diagnostic imaging
Osteomyelitis / metabolism
Osteomyelitis / microbiology*
Osteomyelitis / pathology
Positron-Emission Tomography / methods
Quinolines / administration & dosage
Radiopharmaceuticals
Rifampin / administration & dosage
Spine / pathology
Tomography, X-Ray Computed
Tuberculosis, Osteoarticular / diagnosis*
Tuberculosis, Osteoarticular / diagnostic imaging
Tuberculosis, Osteoarticular / metabolism
Tuberculosis, Osteoarticular / pathology

Substances

Antitubercular Agents
Aza Compounds
Fluoroquinolones
Quinolines
Radiopharmaceuticals
Fluorodeoxyglucose F18
Ethambutol
Moxifloxacin
Rifampin